FDA to review growth hormone safety, follows EU by Susan Heavey WASHINGTON (Reuters) – U.S. health officials are taking a closer look at recombinant human growth hormone products made by Pfizer, Novartis and other drugmakers to see whether they increase the risk of death. The move comes on the heels of a French study that [...]
Read More...
Read More...